Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $1.53 in the prior trading day, Liminatus Pharma Inc (NASDAQ: LIMN) closed at $1.41, down -7.84%. In other words, the price has decreased by -$7.84 from its previous closing price. On the day, 0.5 million shares were traded. LIMN stock price reached its highest trading level at $1.55 during the session, while it also had its lowest trading level at $1.36.
Ratios:
Our goal is to gain a better understanding of LIMN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.17 and its Current Ratio is at 0.17.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 38161132 and an Enterprise Value of 38265412.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.38, which has changed by -0.82462686 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -48.89%, while the 200-Day Moving Average is calculated to be -83.22%.
Shares Statistics:
The stock has traded on average 1.48M shares per day over the past 3-months and 732830 shares per day over the last 10 days, according to various share statistics. A total of 26.01M shares are outstanding, with a floating share count of 5.56M. Insiders hold about 79.47% of the company’s shares, while institutions hold 0.76% stake in the company. Shares short for LIMN as of 1759190400 were 395921 with a Short Ratio of 0.27, compared to 1756425600 on 311749.
